缩短结核病的治疗疗程。 - Suppr

Shortening the treatment of tuberculosis.

作者信息

Mitchison Denis A

出版信息

Nat Biotechnol. 2005 Feb;23(2):187-8. doi: 10.1038/nbt0205-187.

DOI:10.1038/nbt0205-187

PMID:15696148

Abstract

摘要

相似文献

Shortening the treatment of tuberculosis.

Nat Biotechnol. 2005 Feb;23(2):187-8. doi: 10.1038/nbt0205-187.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9.

Microbiology. TB--a new target, a new drug.

Science. 2005 Jan 14;307(5707):214-5. doi: 10.1126/science.1108379.

Medicine. New TB drug promises shorter, simpler treatment.

Science. 2004 Dec 10;306(5703):1872. doi: 10.1126/science.306.5703.1872.

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

Bioorg Med Chem. 2015 Feb 15;23(4):742-52. doi: 10.1016/j.bmc.2014.12.060. Epub 2015 Jan 2.

Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.

Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

J Infect Dis. 2004 Nov 1;190(9):1642-51. doi: 10.1086/424849. Epub 2004 Sep 24.

5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.

J Enzyme Inhib Med Chem. 2010 Dec;25(6):765-72. doi: 10.3109/14756360903425221. Epub 2010 Jun 23.

The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

N Engl J Med. 2009 Jun 4;360(23):2397-405. doi: 10.1056/NEJMoa0808427.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130.

引用本文的文献

Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin.

Clin Infect Dis. 2024 May 15;78(5):1246-1255. doi: 10.1093/cid/ciad700.

Overcoming Drug Resistance: Novel Medications and Repositioning Strategies.

ACS Omega. 2023 Sep 1;8(36):32244-32257. doi: 10.1021/acsomega.3c02563. eCollection 2023 Sep 12.

and Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis.

Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421. doi: 10.1128/AAC.00974-21. Epub 2021 Aug 16.

Deletion of Abates Reactivation of Latent Mycobacterium tuberculosis in Mice.

Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.02095-20.

Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00190-18. Print 2018 Jul.

Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4778-85. doi: 10.1128/AAC.02548-15. Print 2016 Aug.

High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.

Front Microbiol. 2015 Jun 23;6:641. doi: 10.3389/fmicb.2015.00641. eCollection 2015.

Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome.

BMC Complement Altern Med. 2014 Oct 15;14:400. doi: 10.1186/1472-6882-14-400.

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Lancet Infect Dis. 2010 Jun;10(6):387-94. doi: 10.1016/S1473-3099(10)70071-2.

New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.

Antimicrob Agents Chemother. 2009 Mar;53(3):849-62. doi: 10.1128/AAC.00749-08. Epub 2008 Dec 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Shortening the treatment of tuberculosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Shortening the treatment of tuberculosis.

作者信息

出版信息

相似文献

引用本文的文献